Cylert

Lea en español

CylertCylert is the brand name for Pemoline, a stimulant first synthesized in 1913 and used to treat ADHD (attention deficit hyperactivity disorder) and narcolepsy. Pemoline has been pulled from the U.S. market because of reports connecting its use in children to increased risk of liver failure. After the U.S. Food and Drug Administration (FDA) issued a warning not to prescribe Pemoline for ADHD, the manufacturer and patent owner (Abbott Laboratories) stopped making Cylert.

Pemoline was first approved by the FDA in 1975. Since that date, more than 20 liver failures have been linked to the drug. Pemoline is believed to cause hepatoxicity, a chemically induced form of liver damage.

If you or someone you love has used any type of Cylert and experienced detrimental side effects, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

Defective Drugs & Medical Devices Topics

Latest Articles

Divorce and Taxes

  If you are facing a divorce, you know that there are plenty of difficult, even painful questi…

07 Dec 2018, Friday

Legalizing Recreational Marijuana: A New State Revolution?

  Election night 2018 brought about several changes in the legal landscape, but probably none s…

06 Dec 2018, Thursday

The State(s) of Medicaid Expansion

  In 2012, the Patient Protection and Affordable Care Act (“ACA”) made some sweeping chang…

05 Dec 2018, Wednesday